Request for Covid-19 Impact Assessment of this Report
StemCyte (U.S.)
Cryo-Cell International (U.S.)
ViaCord (U.S.)
Cord Blood Registry (U.S.)
Smart Cells (U.K.)
Cryo-Save (Netherlands)
Cryoviva (India)
LifeCell (India)
Cordlife (Singapore)
Cordvida (Brazil)
Cord Blood Corporation (China)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Cord Blood
Cord Tissue
Type III
Split by applications, this report focuses on sales, market share and growth rate of Stem Cell Banking in each application, can be divided into
Cerebral Palsy
Leukemia
Thalassemia
Anemia
United States Stem Cell Banking Sales Market Report 2021
1 Stem Cell Banking Overview
1.1 Product Overview and Scope of Stem Cell Banking
1.2 Classification of Stem Cell Banking
1.2.1 Cord Blood
1.2.2 Cord Tissue
1.2.3 Type III
1.3 Applications of Stem Cell Banking
1.3.1 Cerebral Palsy
1.3.2 Leukemia
1.3.3 Thalassemia
1.3.4 Anemia
1.4 USA Market Size (Value and Volume) of Stem Cell Banking (2011-2021)
1.4.1 USA Stem Cell Banking Sales, Revenue and Price (2011-2021)
1.4.2 USA Stem Cell Banking Sales and Growth Rate (2011-2021)
1.4.3 USA Stem Cell Banking Revenue and Growth Rate (2011-2021)
2 USA Stem Cell Banking Competition by Manufacturers
2.1 USA Stem Cell Banking Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Stem Cell Banking Revenue and Share by Manufactures (2015 and 2016)
3 USA Stem Cell Banking (Volume and Value) by Type
3.1 USA Stem Cell Banking Sales and Market Share by Type (2011-2021)
3.2 USA Stem Cell Banking Revenue and Market Share by Type (2011-2021)
4 USA Stem Cell Banking (Volume) by Application
5 USA Stem Cell Banking Manufacturers Analysis
5.1 StemCyte (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Stem Cell Banking Product Type and Technology
5.1.2.1 Cord Blood
5.1.2.2 Cord Tissue
5.1.3 Stem Cell Banking Sales, Revenue, Price of StemCyte (U.S.) (2015 and 2016)
5.2 Cryo-Cell International (U.S.)
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Medical Devices Product Type and Technology
5.2.2.1 Cord Blood
5.2.2.2 Cord Tissue
5.2.3 Medical Devices Sales, Revenue, Price of Cryo-Cell International (U.S.) (2015 and 2016)
5.3 ViaCord (U.S.)
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 ViaCord (U.S.) Product Type and Technology
5.3.2.1 Cord Blood
5.3.2.2 Cord Tissue
5.3.3 ViaCord (U.S.) Sales, Revenue, Price of ViaCord (U.S.) (2015 and 2016)
5.4 Cord Blood Registry (U.S.)
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 Cordlife (Singapore) Product Type and Technology
5.4.2.1 Cord Blood
5.4.2.2 Cord Tissue
5.4.3 Cord Blood Registry (U.S.) Sales, Revenue, Price of Cord Blood Registry (U.S.) (2015 and 2016)
5.5 Smart Cells (U.K.)
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 Smart Cells (U.K.) Product Type and Technology
5.5.2.1 Cord Blood
5.5.2.2 Cord Tissue
5.5.3 Smart Cells (U.K.) Sales, Revenue, Price of Smart Cells (U.K.) (2015 and 2016)
5.6 Cryo-Save (Netherlands)
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 Cryo-Save (Netherlands) Product Type and Technology
5.6.2.1 Cord Blood
5.6.2.2 Cord Tissue
5.6.3 Cryo-Save (Netherlands) Sales, Revenue, Price of Cryo-Save (Netherlands) (2015 and 2016)
5.7 Cryoviva (India)
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 Cryoviva (India) Product Type and Technology
5.7.2.1 Cord Blood
5.7.2.2 Cord Tissue
5.7.3 Cryoviva (India) Sales, Revenue, Price of Cryoviva (India) (2015 and 2016)
5.8 LifeCell (India)
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 LifeCell (India) Product Type and Technology
5.8.2.1 Cord Blood
5.8.2.2 Cord Tissue
5.8.3 LifeCell (India) Sales, Revenue, Price of LifeCell (India) (2015 and 2016)
5.9 Cordlife (Singapore)
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 Cordlife (Singapore) Product Type and Technology
5.9.2.1 Cord Blood
5.9.2.2 Cord Tissue
5.9.3 Cordlife (Singapore) Sales, Revenue, Price of Cordlife (Singapore) (2015 and 2016)
5.10 Cordvida (Brazil)
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 Cordvida (Brazil) Product Type and Technology
5.10.2.1 Cord Blood
5.10.2.2 Cord Tissue
5.10.3 Cordvida (Brazil) Sales, Revenue, Price of Cordvida (Brazil) (2015 and 2016)
5.11 Cord Blood Corporation (China)
6 Stem Cell Banking Technology and Development Trend
6.1 Stem Cell Banking Technology Analysis
6.2 Stem Cell Banking Technology Development Trend
7 Research Findings and Conclusion
Figure Picture of Stem Cell Banking
Table Classification of Stem Cell Banking
Figure USA Sales Market Share of Stem Cell Banking by Type in 2015
Figure Cord Blood Picture
Figure Cord Tissue Picture
Table Applications of Stem Cell Banking
Figure USA Sales Market Share of Stem Cell Banking by Application in 2015
Figure Cerebral Palsy Examples
Figure Leukemia Examples
Figure Thalassemia Examples
Figure Anemia Examples
Table USA Stem Cell Banking Sales, Revenue and Price (2011-2021)
Figure USA Stem Cell Banking Sales and Growth Rate (2011-2021)
Figure USA Stem Cell Banking Revenue and Growth Rate (2011-2021)
Table USA Stem Cell Banking Sales of Key Manufacturers (2015 and 2016)
Table USA Stem Cell Banking Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Stem Cell Banking Sales Share by Manufacturers
Figure 2016 Stem Cell Banking Sales Share by Manufacturers
Table USA Stem Cell Banking Revenue by Manufacturers (2015 and 2016)
Table USA Stem Cell Banking Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Stem Cell Banking Revenue Share by Manufacturers
Table 2016 USA Stem Cell Banking Revenue Share by Manufacturers
Table USA Stem Cell Banking Sales and Market Share by Type (2011-2021)
Table USA Stem Cell Banking Sales Share by Type (2011-2021)
Figure Sales Market Share of Stem Cell Banking by Type (2011-2021)
Figure USA Stem Cell Banking Sales Growth Rate by Type (2011-2021)
Table USA Stem Cell Banking Revenue and Market Share by Type (2011-2021)
Table USA Stem Cell Banking Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Stem Cell Banking by Type (2011-2021)
Figure USA Stem Cell Banking Revenue Growth Rate by Type (2011-2021)
Table USA Stem Cell Banking Sales and Market Share by Application (2011-2021)
Table USA Stem Cell Banking Sales Share by Application (2011-2021)
Figure Sales Market Share of Stem Cell Banking by Application (2011-2021)
Figure USA Stem Cell Banking Sales Growth Rate by Application (2011-2021)
Table StemCyte (U.S.) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of StemCyte (U.S.) (2015 and 2016)
Table Cryo-Cell International (U.S.) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of Cryo-Cell International (U.S.) (2015 and 2016)
Table ViaCord (U.S.) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of ViaCord (U.S.) (2015 and 2016)
Table Cord Blood Registry (U.S.) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of Cord Blood Registry (U.S.) (2015 and 2016)
Table Smart Cells (U.K.) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of Smart Cells (U.K.) (2015 and 2016)
Table Cryo-Save (Netherlands) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of Cryo-Save (Netherlands) (2015 and 2016)
Table Cryoviva (India) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of Cryoviva (India) (2015 and 2016)
Table LifeCell (India) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of LifeCell (India) (2015 and 2016)
Table Cordlife (Singapore) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of Cordlife (Singapore) (2015 and 2016)
Table Cordvida (Brazil) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of Cordvida (Brazil) (2015 and 2016)
Table Cord Blood Corporation (China) Basic Information List
Table Stem Cell Banking Sales, Revenue, Price of Cord Blood Corporation (China) (2015 and 2016)
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...